<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Kim RG</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Social determinants of health (SDoH) have been associated with disparate outcomes among those with metabolic dysfunction-associated steatotic liver disease (MASLD) and its risk factors. To address SDoH among this population, real-time SDoH screening in clinical settings is required, yet optimal screening methods are unclear. We performed a scoping review to describe the current literature on SDoH screening conducted in the clinical setting among individuals with MASLD and MASLD risk factors.&lt;h4>Methods&lt;/h4>Through a systematic literature search of MEDLINE, Embase, and CINAHL Complete databases through 7/2023, we identified studies with clinic-based SDoH screening among individuals with or at risk for MASLD that reported pertinent clinical outcomes including change in MAS</pubmed_abstract><journal>Frontiers in public health</journal><pagination>1332870</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11041393</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Screening for social determinants of health among populations at risk for MASLD: a scoping review.</pubmed_title><pmcid>PMC11041393</pmcid><pubmed_authors>Price JC</pubmed_authors><pubmed_authors>Kim RG</pubmed_authors><pubmed_authors>Ballantyne A</pubmed_authors><pubmed_authors>Inadomi JM</pubmed_authors><pubmed_authors>Conroy MB</pubmed_authors></additional><is_claimable>false</is_claimable><name>Screening for social determinants of health among populations at risk for MASLD: a scoping review.</name><description>&lt;h4>Background&lt;/h4>Social determinants of health (SDoH) have been associated with disparate outcomes among those with metabolic dysfunction-associated steatotic liver disease (MASLD) and its risk factors. To address SDoH among this population, real-time SDoH screening in clinical settings is required, yet optimal screening methods are unclear. We performed a scoping review to describe the current literature on SDoH screening conducted in the clinical setting among individuals with MASLD and MASLD risk factors.&lt;h4>Methods&lt;/h4>Through a systematic literature search of MEDLINE, Embase, and CINAHL Complete databases through 7/2023, we identified studies with clinic-based SDoH screening among individuals with or at risk for MASLD that reported pertinent clinical outcomes including change in MAS</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-22T20:43:57.336Z</modification><creation>2025-04-06T03:14:49.654Z</creation></dates><accession>S-EPMC11041393</accession><cross_references><pubmed>38660357</pubmed><doi>10.3389/fpubh.2024.1332870</doi></cross_references></HashMap>